These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes. Kinoshita T, Rosenfeld SI, Nussenzweig V. J Immunol; 1987 May 01; 138(9):2994-8. PubMed ID: 2437202 [Abstract] [Full Text] [Related]
5. Decay-accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA). Ninomiya H, Abe T, Shichishima T, Terasawa T, Fujita T. Br J Haematol; 1988 May 01; 69(1):81-7. PubMed ID: 2454648 [Abstract] [Full Text] [Related]
6. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Okuda K, Kanamaru A, Ueda E, Kitani T, Okada N, Okada H, Kakishita E, Nagai K. Exp Hematol; 1990 Nov 01; 18(10):1132-6. PubMed ID: 1698649 [Abstract] [Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria and decay-accelerating factor. Rosse WF. Annu Rev Med; 1990 Jun 01; 41():431-6. PubMed ID: 1691902 [Abstract] [Full Text] [Related]
16. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Br J Haematol; 1993 Oct 01; 85(2):378-86. PubMed ID: 7506570 [Abstract] [Full Text] [Related]
17. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Kinoshita T, Medof ME, Silber R, Nussenzweig V. J Exp Med; 1985 Jul 01; 162(1):75-92. PubMed ID: 2409211 [Abstract] [Full Text] [Related]